Severe COVID 19 Pneumonia
4 clinical trials · Condition
◉ Watch Severe COVID 19 Pneumonia
| Record | Firm | Date |
|---|---|---|
| Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19 (NCT04924829) | Hospital Italiano de Buenos Aires | 2021-06-01 |
| A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019(COVID-19)Pneumonia (NCT04880694) | Grand Medical Pty Ltd. | 2021-05-20 |
| ANTIcoagulation in Severe COVID-19 Patients (NCT04808882) | Assistance Publique - Hôpitaux de Paris | 2021-04-14 |
| Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia (NCT04333420) | InflaRx GmbH | 2020-03-31 |
Track Severe COVID 19 Pneumonia automatically
Every clearance here is in the API, with alerts when new ones post.